HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph Herbert Selected Research

Multiple Sclerosis

1/2017Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
6/2015An ImmunoChip study of multiple sclerosis risk in African Americans.
2/2015Relationship between iron accumulation and white matter injury in multiple sclerosis: a case-control study.
10/2014IV immunoglobulin confounds JC virus antibody serostatus determination.
1/2013Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis.
3/2012Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI.
1/2012Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.
1/2012Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome.
6/2011Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium.
12/2009Prognosis of the individual course of disease: the elements of time, heterogeneity and precision.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph Herbert Research Topics

Disease

10Multiple Sclerosis
01/2017 - 12/2009
3Relapsing-Remitting Multiple Sclerosis
01/2013 - 06/2004
2Disease Progression
02/2015 - 02/2015
1Neoplasms (Cancer)
04/2022
1Neoplasm Metastasis (Metastasis)
04/2022
1Prediabetic State (Prediabetes)
06/2021
1Neuromyelitis Optica (Devic's Disease)
02/2015
1Hypercapnia
10/2014
1Migraine Disorders (Migraine)
01/2012
1Localized Scleroderma (Morphea)
11/2008
1Seizures (Absence Seizure)
11/2008
1Fatigue
02/2008
1Addison Disease (Addison's Disease)
02/2008

Drug/Important Bio-Agent (IBA)

3Protons (Proton)IBA
01/2017 - 03/2010
2Biomarkers (Surrogate Marker)IBA
02/2015 - 01/2012
1lime (calcium oxide)FDA Link
06/2021
1Hemoglobins (Hemoglobin)IBA
06/2021
1Metformin (Glucophage)FDA LinkGeneric
06/2021
1AT 130IBA
06/2015
1IronIBA
02/2015
1Rituximab (Mabthera)FDA Link
02/2015
1Carbon DioxideIBA
10/2014
1Vasodilator Agents (Vasodilators)IBA
10/2014
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2014
1InterferonsIBA
01/2013
1Interferon beta-1aFDA Link
01/2013
1Oxygen (Dioxygen)IBA
03/2012
1ORALIT (ORS)IBA
01/2012
1Oligoclonal BandsIBA
11/2008
1MineralocorticoidsIBA
02/2008
1GlucocorticoidsIBA
02/2008
1Dehydroepiandrosterone (DHEA)IBA
02/2008
1Contrast MediaIBA
06/2004

Therapy/Procedure

5Therapeutics
01/2013 - 02/2008
1Radiotherapy
04/2022